Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03347071 · ClinicalTrials.gov registry record
Effects of a Yoga-Based Course in Preventing Disordered Eating in Female Collegiate Athletes
A clinical trial, sponsored by University at Buffalo.
- Completed
- Registry status
- 108
- Enrollment target
NCT03347071: Completed study, sponsored by University at Buffalo.
NCT03347071 is a clinical trial that has completed, run by University at Buffalo. The registered enrollment target is 108 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03347071 has completed, sponsored by University at Buffalo.
- COMPLETED
- Registry status
- 108 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate effects of a 7-week undergraduate course, incorporating Eat Breathe Thrive program curriculum, offered to female student-athletes in order to increase positive body image, emotional regulation, interoceptive awareness, self-care skills, and intuitive eating. The undergraduate course is structured around the Eat Breathe Thrive program curriculum, which aims to: a) teach somatic practices that increase interoceptive awareness, b) provide healthy tools for emotional regulation, c) allow for the creation of community-based networks of support, and (d) foster a sense of meaning and purpose through service activities. In a non-randomized controlled trial, the investigators plan to examine whether this preventative undergraduate course is found effective in a female student-athlete population in preventing and decreasing eating disorder risk. The investigators also plan to examine whether the program is found effective in increasing protective factors, such as self-care behaviors, interoceptive awareness, intuitive eating, and emotional regulation skills.
Primary Outcome
Change in Eating Disorder Examination Questionnaire
Interventions
- BEHAVIORAL Prevention Course Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2018-01-24 |
| Est. Completion | 2019-06-30 |
What the finished NCT03347071 record still lists
NCT03347071 is an observational study that tracks outcomes without assigning an intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Prevention Course Group is the first listed.
NCT03347071 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03347071 about?
NCT03347071 is a clinical study titled "Effects of a Yoga-Based Course in Preventing Disordered Eating in Female Collegiate Athletes". The purpose of the study is to evaluate effects of a 7-week undergraduate course, incorporating Eat Breathe Thrive program curriculum, offered to female student-athletes in order to increase positive body image, emotional regulation, interoceptive awareness, self-care skills, and intuitive eating. T...
What is the current status of trial NCT03347071?
This trial is currently completed. The enrollment target is 108 participants. The study started on 2018-01-24. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT03347071?
The interventions under investigation include: Prevention Course Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT03347071?
This trial is sponsored by University at Buffalo, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI